PharmaCielo Ltd. (TSXV:PCLO)
Canada · Delayed Price · Currency is CAD 0.0650
-0.0100 (-13.33%)
Aug 10, 2026, 3:59 PM EST
PharmaCielo Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.54 | 3.97 | 1.54 | 5.31 | 1.94 | |
Revenue Growth | -36.06% | 157.28% | -70.96% | 172.93% | -26.71% |
Cost of Revenue | 1.81 | 3.5 | 2.91 | 4.63 | 6.09 |
Gross Profit | 0.73 | 0.47 | -1.37 | 0.68 | -4.15 |
Selling, General & Admin | 3.98 | 6.39 | 8.31 | 11.66 | 19.15 |
Depreciation & Amortization Expenses | 0.08 | 0.23 | 0.34 | 0.45 | 1.32 |
Other Operating Expenses | - | 1.06 | 4.26 | 1.27 | 0.42 |
Total Operating Expenses | 4.06 | 7.68 | 12.91 | 13.38 | 20.89 |
Operating Income | -3.34 | -7.22 | -14.28 | -12.7 | -25.03 |
Interest Income | - | 0 | 0 | 0 | 0 |
Interest Expense | -2.52 | -4.24 | -2.86 | -1.59 | -0.56 |
Other Non-Operating Income (Expense) | 1.99 | -0.51 | -0.12 | -1.73 | -0.07 |
Total Non-Operating Income (Expense) | -0.53 | -4.75 | -2.98 | -3.32 | -0.63 |
Pretax Income | -3.87 | -11.97 | -17.26 | -16.03 | -25.66 |
Net Income | -3.87 | -11.97 | -16.3 | -14.52 | -26.63 |
Net Income to Common | -3.87 | -11.97 | -16.3 | -14.52 | -26.63 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 188 | 174 | 160 | 151 | 146 |
Shares Outstanding (Diluted) | 188 | 174 | 160 | 151 | 146 |
Shares Change | 8.09% | 8.93% | 6.03% | 3.67% | 29.41% |
EPS (Basic) | -0.02 | -0.07 | -0.10 | -0.10 | -0.18 |
EPS (Diluted) | -0.02 | -0.07 | -0.10 | -0.10 | -0.18 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -4.61 | -2.11 | -5.17 | -10.4 | -21.21 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.02 | -0.01 | -0.03 | -0.07 | -0.15 |
Gross Margin | 28.59% | 11.77% | -88.78% | 12.83% | -213.23% |
Operating Margin | -131.68% | -181.90% | -926.05% | -239.28% | -1287.03% |
Profit Margin | -152.44% | -301.70% | -1057.09% | -273.45% | -1369.14% |
FCF Margin | -181.86% | -53.10% | -335.01% | -195.86% | -1090.55% |
EBITDA | -2.6 | -5.57 | -12.86 | -11.12 | -23.78 |
EBITDA Margin | -102.40% | -140.51% | -834.31% | -209.53% | -1222.43% |
EBIT | -3.34 | -7.22 | -14.28 | -12.7 | -25.03 |
EBIT Margin | -131.68% | -181.90% | -926.05% | -239.28% | -1287.03% |